According to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments could offset the impact. ICICI Securities said the company will use the proceeds to clear its outstanding debt of 4,340 crore as of FY23 but the transaction is likely to result in an earnings cut of 5% for FY25. The brokerage has a sell rating on the stock with a price target of 660.
Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.
Baptist upset Penguins in tight battle examiner.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from examiner.com.au Daily Mail and Mail on Sunday newspapers.
Aster DM Healthcares founder Azad Moopen is in talks to sell a controlling stake in the India-listed hospital company to private equity firms including Blackstone and KKR. The company operates 32 hospitals in West Asia and India, as well as clinics, pharmacies, laboratories and patient experience centres. The discussions are preliminary and focus on a reverse merger with Care Hospitals, though both funds reportedly want a controlling stake or agreed path to control.